Table 5 Distribution of papers based on study design and effectiveness
Effectiveness: (1. statistically significant, 2. positive without statistical argument, 3.not effective (not statistically significant)) Row Labels | Not effective | Positive without statistical argument | Statistically significant at all evaluation scales | Statistically significant on some evaluation scales | Statistically significant only for some children | Grand Total |
|---|---|---|---|---|---|---|
Experimental | Â | Â | 7 | 2 | Â | 9 |
Partially Randomized clinical trial | Â | Â | 1 | Â | Â | 1 |
Randomized controlled trial | Â | Â | 6 | 2 | Â | 8 |
Quasi-experimental | 4 | 1 | 9 | 3 | 1 | 18 |
Before & After Clinical Trial (without control) | 3 | 1 | 7 | 1 | 1 | 13 |
Non-randomized Controlled Clinical Trial | 1 | Â | 2 | 2 | Â | 5 |
Quasi-experimental& Experimental | Â | Â | 1 | Â | Â | 1 |
Phase 1: Before & After Clinical Trial (without control) Phase 2: Randomized controlled trial with two intervention groups and controls | Â | Â | 1 | Â | Â | 1 |
Grand Total | 4 | 1 | 17 | 5 | 1 | 28 |